Multilayered precision regulation to induce robust CD8⁺ T-cell immune responses

References

[1] Wang J, Li P, Yu Y, et al. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 2020; 367(6480).

[2] Katsikis PD, Ishii KJ, Schliehe C. Challenges in developing personalized neoantigen cancer vaccines. Nat Rev Immunol. 2024; 24(3): 213-227.

[3] Wang J, Xie X, Jiang S, Lu L. Immunoengineered adjuvants for universal vaccines against respiratory viruses. Fund Res. 2021; 1(2): 189-192.

[4] Li Y, Mo J, Liu J, et al. A micro-electroporation/electrophoresis-based vaccine screening system reveals the impact of vaccination orders on cross-protective immunity. iScience. 2023; 26(10): 108086.

[5] Wang X, Huang Z, Xing L, et al. STING agonist-based ER-targeting molecules boost antigen cross-presentation. Nature. 2025; 641(8061): 202-210.

[6] Wang J, Chen HJ, Hang T, et al. Physical activation of innate immunity by spiky particles. Nat Nanotechnol. 2018; 13(11): 1078-1086.

[7] Wang Y, Xiang X, Chen H, et al. Intratumoral erythroblastic islands restrain anti-tumor immunity in hepatoblastoma. Cell Rep Med. 2023; 4(5): 101044.

[8] Hou Y, Lin B, Xu T, et al. The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer. Nat Commun. 2024; 15(1): 5555.

[9] Liu J, Jiang J, He M, et al. Nanopore electroporation device for DNA transfection into various spreading and nonadherent cell types. ACS Appl Mater Interfaces. 2023; 15(43): 50015-50033.

[10] Liu X, Jiang J, Liu J, et al. Nanoneedle array-electroporation facilitates intranuclear ribonucleoprotein delivery and high throughput gene editing. Adv Healthc Mater. 2024; 13(29): e2400645.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.